Methods of treating alcohol abuse disorder
AssigneeThe Trustees of Columbia University in the City of New York
InventorsJosé Leonardo WALEWSKI, Paul David BERK
Life of this patent
Estimating the term…
Abstract
The invention provides for methods of treating alcohol abuse disorder.
Claims25
A method for treating alcohol abuse disorder in a subject, the method comprising administering to a subject an effective amount of Spexin.
A method for treating alcohol abuse disorder in a subject, the method comprising administering to a subject in need thereof a polypeptide comprising SEQ ID NO:
- 1, or a pharmaceutically acceptable salt thereof.
A method for treating alcohol abuse disorder in a subject, the method comprising administering to a subject in need thereof a polypeptide comprising SEQ ID NO:
- 3 or 4, or a pharmaceutically acceptable salt thereof.
A method for reducing alcohol consumption in a subject afflicted with alcohol abuse disorder, the method comprising administering to the subject an effective amount of Spexin.
A method for reducing alcohol consumption in a subject afflicted with alcohol abuse disorder, the method comprising administering to the subject a polypeptide comprising SEQ ID NO:
- 1, or a pharmaceutically acceptable salt thereof.
A method for reducing alcohol consumption in a subject afflicted with alcohol abuse disorder, the method comprising administering to the subject a polypeptide comprising SEQ ID NO:
- 3 or 4, or a pharmaceutically acceptable salt thereof.
A method for promoting the cessation of alcohol consumption in a subject afflicted with alcohol abuse disorder, the method comprising administering to the subject an effective amount of Spexin.
A method for promoting the cessation of alcohol consumption in a subject afflicted with alcohol abuse disorder, the method comprising administering to the subject a polypeptide comprising SEQ ID NO:
- 1, or a pharmaceutically acceptable salt thereof.
A method for promoting the cessation of alcohol consumption in a subject afflicted with alcohol abuse disorder, the method comprising administering to the subject a polypeptide comprising SEQ ID NO:
- 3 or 4, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.